Attractive returns and the breadth of opportunities are among the many reasons why investors have historically preferred investing in the U.S. to
Tag: Novo Nordisk A/S
These are the top 5 companies to work for in India, says LinkedIn
These are the 2024 top companies in India, according to LinkedIn. Deepak Sethi | E+ | Getty Images LinkedIn has released its
A top NVDA shareholder reveals his trigger for selling growth stocks
Nvidia shares have continued to soar this year, up more than 80%. But one of its top shareholders has revealed why they’ve
Amgen aims to enter weight loss drug market with a new approach
The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images Amgen
How much people are willing to spend
Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters
New funds target weight loss, Big Tech hype: Roundhill Investments
A major exchange-traded fund provider is going deep on two popular plays: megacap tech and weight loss drug stocks. In health care,
Wegovy heart health approval won’t mean broad insurance coverage yet
Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a
WeightWatchers CEO just sent a memo to employees as stock crashes
Sima Sistani, CEO, WW International, August 16, 2023. Scott Mlyn | CNBC WeightWatchers CEO Sima Sistani has sent an internal memo to
FDA approves NASH liver disease drug from Madrigal Pharmaceuticals
In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen. Rafael Henrique | SOPA Images | Lightrocket |
Eli Lilly hits another Alzheimer’s hurdle. But obesity, diabetes GLP-1s strong
Eli Lilly ‘s experimental Alzheimer’s treatment hit another hurdle with U.S. drug regulators. It pushed out the timeline for potential approval but
No More Posts Available.
No more pages to load.